Novartis AG (NYSE:NVS)

89.18
Delayed Data
As of Nov 25
 +0.88 / +1.00%
Today’s Change
69.18
Today|||52-Week Range
99.84
-5.82%
Year-to-Date
Should Value Investors Consider Novartis (NVS) Stock Now?
Nov 25 / Zacks.com - Paid Partner Content
Alnylam (ALNY) Gets EU Nod for Oxlumo to Treat Renal Disease
Nov 20 / Zacks.com - Paid Partner Content
Alnylam (ALNY) Gets FDA Nod for Oxlumo to Treat Renal Disease
Nov 25 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: PFE COVID-19 Vaccine Final Analysis, FDA Updates & More
Nov 20 / Zacks.com - Paid Partner Content
3 Healthcare IPOs to Watch This Month
Nov 21 / MotleyFool.com - Paid Partner Content
Sanofi (SNY) Pompe Disease Drug Gets FDA's Priority Tag
Nov 19 / Zacks.com - Paid Partner Content
Why Mesoblast Stock Is Blasting Off Today
Nov 20 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks That Could Have Tripled Your Money This Year
Nov 15 / MotleyFool.com - Paid Partner Content
Novartis (NVS) Partners With Mesoblast for ARDS Cell Therapy
Nov 20 / Zacks.com - Paid Partner Content
3 Top Biotech Stocks to Watch in November
Nov 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close88.30
Today’s open89.06
Day’s range88.89 - 89.56
Volume2,030,329
Average volume (3 months)1,857,721
Market cap$199.1B
Data as of 3:59pm ET, 11/25/2020

Growth & Valuation

Earnings growth (last year)-43.54%
Earnings growth (this year)+7.19%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)-8.60%
P/E ratio28.9
Price/Sales4.62
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.08-0.10%
PFEPfizer-0.08-0.22%
ABBVAbbVie+0.25+0.24%
BMYBristol-Myers Squibb-0.31-0.49%
Data as of 7:19pm ET, 11/25/2020

Financials

Next reporting dateJanuary 26, 2021
EPS forecast (this quarter)$1.38
Annual revenue (last year)$47.5B
Annual profit (last year)$7.0B
Net profit margin15.04%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts